Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats

Abstract

Background:

The dorsal hippocampus has a central role in modulating cardiovascular responses and behavioral adaptation to stress. The dorsal hippocampus also plays a key role in stress-associated mental disorders. The endocannabinoid system is widely expressed in the dorsal hippocampus and modulates defensive behaviors under stressful conditions. The endocannabinoid anandamide activates cannabinoid type 1 receptors and is metabolized by the fatty acid amide hydrolase enzyme.

Aims:

We sought to verify whether cannabinoid type 1 receptors modulate stress-induced cardiovascular changes, and if pharmacological fatty acid amide hydrolase inhibition in the dorsal hippocampus would prevent the cardiovascular responses and the delayed anxiogenic-like behavior evoked by restraint stress in rats via cannabinoid type 1 receptors.

Methods:

Independent groups received intra-dorsal-hippocampal injections of N-(piperidin-1yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-hpyrazole-3-carboxamide (AM251; cannabinoid type 1 receptor antagonist/inverse agonist, 10–300 pmol) and/or cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597; fatty acid amide hydrolase inhibitor, 10 pmol) before the restraint stress session. Cardiovascular response during restraint stress or later behavioral parameters were evaluated.

Results:

Acute restraint stress altered the cardiovascular response, characterized by increased heart rate and mean arterial pressure, as well as decreased tail cutaneous temperature. It also induced a delayed anxiogenic-like effect, evidenced by reduced open arm exploration in the elevated plus maze 24 h after stress. AM251 exacerbated the stress-induced cardiovascular responses after injection into the dorsal hippocampus. In contrast, local injection of URB597 prevented the cardiovascular response and the delayed (24 h) behavioral consequences of restraint stress, effects attenuated by pretreatment with AM251.

Conclusion:

Our data corroborate previous results indicating that the hippocampal endocannabinoid system modulates the outcome of stress exposure and suggest that this could involve modulation of the cardiovascular response during stress exposure.

Keywords

Endocannabinoid system cannabinoid type 1 receptors dorsal hippocampus autonomic responses anxiety

Get full access to this article

View all access options for this article.

References

Bird

Burgess

(2008) The hippocampus and memory: Insights from spatial processing. Nat Rev Neurosci 9: 182–194.

Campos

Ferreira

Guimaraes

et al . (2010) Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience 167: 238–246.

Carnevali

Rivara

Nalivaiko

et al . (2017) Pharmacological inhibition of FAAH activity in rodents: A promising pharmacological approach for psychological-cardiac comorbidity? Neurosci Biobehav Rev 74: 444–452.

Carnevali

Vacondio

Rossi

et al . (2015a) Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats. Eur Neuropsychopharmacol 25: 2157–2169.

Carnevali

Vacondio

Rossi

et al . (2015b) Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety. Sci Rep 5: 18218.

Cravatt

Giang

Mayfield

et al . (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83–87.

Devane

Dysarz

Johnson

et al . (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605–613.

Devane

Hanus

Breuer

et al . (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946–1949.

Dinh

Carpenter

Leslie

et al . (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99: 10819–10824.

10.

Egertová

Simon

Cravatt

et al . (2008) Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules. J Comp Neurol 506: 604–615.

11.

Fabri

Hott

Reis

et al . (2014) The expression of contextual fear conditioning involves activation of a NMDA receptor-nitric oxide-cGMP pathway in the dorsal hippocampus of rats. Eur Neuropsychopharmacol 24: 1676–1686.

12.

Giancola

Roder

Ciriello

(1993) Contribution of caudal ventrolateral medulla to the cardiovascular responses elicited by activation of bed nucleus of the stria terminalis. Brain Res 606: 162–166.

13.

Gray

Magnuson

(1987) Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat. J Comp Neurol 262: 365–374.

14.

Grippo

Johnson

(2009) Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 12: 1–21.

15.

Herman

Cullinan

Watson

(1994) Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J Neuroendocrinol 6: 433–442.

16.

Joca

Ferreira

Guimarães

(2007) Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems. Stress 10: 227–249.

17.

Katona

Rancz

Acsády

et al . (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21: 9506–9518.

18.

Katona

Sperlágh

Sı́k

et al . (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544–4558.

19.

Lafourcade

Elezgarai

Mato

et al . (2007) Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One 2: e709.

20.

Lisboa

Borges

Nejo

et al . (2015) Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence. Prog Neuropsychopharmacol Biol Psychiatry 59: 76–83.

21.

Lisboa

Gomes

Terzian

et al . (2017) The endocannabinoid system and anxiety. In: Litwack

(ed.) Anxiety. Vol. 103, pp. 193–279. UK: Academic Press.

22.

Lisboa

Reis

da Silva

et al . (2010) Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int J Neuropsychopharmacol 13: 1163–1173.

23.

Lisboa

Resstel

Aguiar

et al . (2008) Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. Eur J Pharmacol 593: 73–78.

24.

Marsicano

Lutz

(1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11: 4213–4225.

25.

Marsicano

Wotjak

Azad

et al . (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530–534.

26.

Mechoulam

Ben-Shabat

Hanus

et al . (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83–90.

27.

Menard

Treit

(2001) The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal L-glutamate. Brain Res 888: 163–166.

28.

Moraes-Neto

Scopinho

Biojone

et al . (2014) Involvement of dorsal hippocampus glutamatergic and nitrergic neurotransmission in autonomic responses evoked by acute restraint stress in rats. Neuroscience 258: 364–373.

29.

Myers

(2017) Corticolimbic regulation of cardiovascular responses to stress. Physiol Behav 172: 49–59.

30.

Onaivi

Ishiguro

Gong

et al . (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074: 514–536.

31.

Padovan

Del Bel

Guimaraes

(2000) Behavioral effects in the elevated plus maze of an NMDA antagonist injected into the dorsal hippocampus: Influence of restraint stress. Pharmacol Biochem Behav 67: 325–330.

32.

Paxinos

Watson

(2006) The Rat Brain in Stereotaxic Coordinates. 5th ed. San Diego: Academic Press.

33.

Puente

Elezgarai

Lafourcade

et al . (2010) Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalis. PLoS One 5: e8869.

34.

Ramikie

Nyilas

Bluett

et al . (2014) Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron 81: 1111–1125.

35.

Resstel

Joca

Correa

et al . (2008a) Effects of reversible inactivation of the dorsal hippocampus on the behavioral and cardiovascular responses to an aversive conditioned context. Behav Pharmacol 19: 137–144.

36.

Resstel

Lisboa

Aguiar

et al . (2008b) Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats. Psychopharmacology (Berl) 198: 405–411.

37.

Rezayat

Roohbakhsh

Zarrindast

et al . (2005) Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Physiol Behav 84: 775–782.

38.

Ruit

Neafsey

(1988) Cardiovascular and respiratory responses to electrical and chemical stimulation of the hippocampus in anesthetized and awake rats. Brain Res 457: 310–321.

39.

Schneiderman

Ironson

Siegel

(2005) Stress and health: psychological, behavioral, and biological determinants. Annu Rev Clin Psychol 1: 607–628.

40.

Scopinho

Lisboa

Guimaraes

et al . (2013) Dorsal and ventral hippocampus modulate autonomic responses but not behavioral consequences associated to acute restraint stress in rats. PLoS One 8: e77750.

41.

Spiacci

Antero

Reis

et al . (2016) Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic neurotransmissions. Eur Neuropsychopharmacol 26: 1579–1589.

42.

Spolidorio

Echeverry

Iyomasa

et al . (2007) Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus. Psychopharmacology (Berl, 195: 183–192.

43.

Strange

Witter

Lein

et al . (2014) Functional organization of the hippocampal longitudinal axis. Nat Rev Neurosci 15: 655–669.

44.

Yoshida

Fukaya

Uchigashima

et al . (2006) Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 26: 4740–4751.